Baird Downgrades BioMarin Pharmaceutical To Neutral By: Benzinga via Benzinga June 19, 2015 at 10:31 AM EDT Baird downgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Outperform to Neutral. BioMarin Pharmaceutical shares have gained ... Read More >> Related Stocks: Biomarin Pharmaceuticals